Phenoxyether derivatives as PPAR modulators

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S557000, C546S290000, C562S465000

Reexamination Certificate

active

07608639

ABSTRACT:
The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR), such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.

REFERENCES:
patent: 0 307 103 (1988-08-01), None
patent: 0 307 103 (1988-08-01), None
patent: 0 597 102 (1992-07-01), None
patent: 0 696 585 (1994-04-01), None
patent: 0 647 612 (1994-09-01), None
patent: 1563871 (1980-04-01), None
patent: 08 059 638 (1996-03-01), None
patent: WO 2004/093799 (2004-11-01), None
Crews, A.D. et al, “Synthesis and Herbalicidal Activity of bis-Aryloxybenzenes: A New Structural Class of Protox Inhibitors Derived from N-Phenyl Benzotriazoles”, ACS Symposium Series, 686 (Synthesis and Chemistry of Argochemicals V), 48-54 CODEN: ACSMC8; ISSN: 0097-6156, 1998, XP009044229.
Ebisawa, M. et al, “Thiazolidinediones With Thyroid Hormone Receptor Agonistic Activity”, Chemical and Pharmaceutical Bulletin, Pharmaceutical Society of Japan. Tokyo, JP, vol. 47, No. 9, 1999, pp. 1348-1350, XP000906992; ISSN: 0009-2363.
Hutter, Michael C. et al, “QSAR of human steriod 5. alpha-reductase inhibitors: Where are the differences between isoenzyme type 1 and 2?”, Chemical Abstracts Services, XP002318310 retrieved from STN, 2004.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Phenoxyether derivatives as PPAR modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenoxyether derivatives as PPAR modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenoxyether derivatives as PPAR modulators will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4076906

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.